Location: Palo Alto, CA
CIK: 0001664974 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $143M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OKLO | Oklo Inc. | 6,920,804 | $58.62M | 41.1% | $11.25 | 0.0% | COM CL A | 02156V109 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $44.56M | 31.2% | $18.82 | -53.6% | CL A | 75629V104 |
| EVLV | Evolv Technologies Holdings, Inc. | 9,681,281 | $24.69M | 17.3% | $5.61 | -41.0% | COM CL A | 30049H102 |
| — | Rocket Lab USA, Inc. | 2,929,350 | $14.06M | 9.9% | $4.04 | — | COM | 773122106 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $724K | 0.5% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $40,959 | 0.0% | $5.56 | +97.0% | SHS | G76279101 |